These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6424820)

  • 1. Flexible induction dose regimen for warfarin and prediction of maintenance dose.
    Fennerty A; Dolben J; Thomas P; Backhouse G; Bentley DP; Campbell IA; Routledge PA
    Br Med J (Clin Res Ed); 1984 Apr; 288(6426):1268-70. PubMed ID: 6424820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A flexible loading dose schedule for warfarin therapy.
    Fergusson RJ; Eade OE; Logie AW; Gaddie J
    Scott Med J; 1987 Dec; 32(6):169-71. PubMed ID: 3329767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple technique for predicting maintenance dosage of warfarin--is it better than empirical dosing?
    Ovesen L; Lyduch S; Ott P
    Eur J Clin Pharmacol; 1989; 37(6):573-6. PubMed ID: 2612552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged hospitalization because of inappropriate delay of warfarin therapy in deep venous thrombosis.
    Westblom TU; Marienfeld RD
    South Med J; 1985 Oct; 78(10):1164-7. PubMed ID: 4049032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of a flexible protocol for starting treatment with warfarin and predicting its maintenance dose.
    Cosh DG; Moritz CK; Ashman KJ; Dally RJ; Gallus AS
    Aust N Z J Med; 1989 Jun; 19(3):191-7. PubMed ID: 2775039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.
    Hull R; Delmore T; Genton E; Hirsh J; Gent M; Sackett D; McLoughlin D; Armstrong P
    N Engl J Med; 1979 Oct; 301(16):855-8. PubMed ID: 384248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response.
    Sawyer WT; Poe TE; Canaday BR; Weiner JS; Williams DM; Webb CE; Ellison MJ
    Clin Pharm; 1985; 4(4):440-6. PubMed ID: 3899472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
    Le Gal G; Carrier M; Tierney S; Majeed H; Rodger M; Wells PS
    J Thromb Haemost; 2010 Jan; 8(1):90-4. PubMed ID: 19874475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
    Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
    Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting warfarin maintenance dosage based on initial response.
    Miller DR; Brown MA
    Am J Hosp Pharm; 1979 Oct; 36(10):1351-5. PubMed ID: 507078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple technic for predicting daily maintenance dose of warfarin.
    Williams DB; Karl RC
    Am J Surg; 1979 Apr; 137(4):572-6. PubMed ID: 426209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin and warfarin: use of anticoagulants in the prevention and treatment of venous thrombosis and pulmonary embolism.
    Rosen RL
    J Fam Pract; 1979 May; 8(5):923-7. PubMed ID: 438753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary warfarin resistance.
    Diab F; Feffer S
    South Med J; 1994 Mar; 87(3):407-9. PubMed ID: 8134868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation.
    Ascani A; Iorio A; Agnelli G
    Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
    Hull RD; Raskob GE; Rosenbloom D; Panju AA; Brill-Edwards P; Ginsberg JS; Hirsh J; Martin GJ; Green D
    N Engl J Med; 1990 May; 322(18):1260-4. PubMed ID: 2183055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of age with dosage requirement for warfarin.
    Redwood M; Taylor C; Bain BJ; Matthews JH
    Age Ageing; 1991 May; 20(3):217-20. PubMed ID: 1906677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating patients' warfarin requirements.
    Jones BR; Baran A; Reidenberg MM
    J Am Geriatr Soc; 1980 Jan; 28(1):10-2. PubMed ID: 7350210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin dosage requirements: prospective clinical trial of a method for prediction from the response to a single dose.
    Jupe DM; Peterson GM; Coleman RL; McLean S
    Br J Clin Pharmacol; 1988 May; 25(5):607-10. PubMed ID: 3044427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease.
    Kovacs MJ; Cruickshank M; Wells PS; Kim H; Chin-Yee I; Morrow B; Boyle E; Kovacs J
    Haemostasis; 1998; 28(2):62-9. PubMed ID: 10087430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.